Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Lipid Research

• Publication date

  1996-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 8978489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.

  1997cited by this paper
• The genotoxicity profile of atorvastatin, a new drug in the treatment of hypercholesterolemia.

  1995cited by this paper
• Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.

  1995cited by this paper
• Comparative effects of HMG-CoA reductase inhibitors on apo B production in the casein-fed rabbit: atorvastatin versus lovastatin.

  1995cited by this paper
• The effects of simvastatin and cholestyramine, alone and in combination, on hepatic cholesterol metabolism in the male rat

  1995cited by this paper
• Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia.

  1995cited by this paper
• Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor.

  1995cited by this paper
• Carbohydrate-fat exchange and regulation of hepatic cholesterol and plasma lipoprotein metabolism in the guinea pig.

  1995cited by this paper
• Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in the rat ileum: effects of bile acids and lovastatin.

  1994cited by this paper
• Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation.

  1994cited by this paper
• Citrus pectin and cholesterol interact to regulate hepatic cholesterol homeostasis and lipoprotein metabolism: a dose-response study in guinea pigs.

  1994cited by this paper
• Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.

  1994cited by this paper
• The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats.

  1994cited by this paper
• Cholesterol synthesis inhibitors inhibit more than cholesterol synthesis.

  1994cited by this paper
• Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemic subjects.

  1993cited by this paper
• Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts.

  1993cited by this paper
• HMG-CoA reductase inhibitors: a look back and a look ahead.

  1992cited by this paper
• The discovery and development of HMG-CoA reductase inhibitors.

  1992cited by this paper
• Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat.

  1992cited by this paper
• Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors.

  1992cited by this paper
• Silver-enhanced radial immunodiffusion assay of plasma apolipoproteins.

  1992cited by this paper
• Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis.

  1992cited by this paper
• Mechanisms of hypertriglyceridemia in the coconut oil/cholesterol-fed rabbit. Increased secretion and decreased catabolism of very low density lipoprotein.

  1991cited by this paper
• Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis.

  1990cited by this paper
• Lipoprotein physiology and its relationship to atherogenesis.

  1990cited by this paper
• Dietary fat-mediated changes in hepatic apoprotein B/E receptor in the guinea pig: effect of polyunsaturated, monounsaturated, and saturated fat.

  1989cited by this paper
• Effects of lovastatin therapy on guinea pig low density lipoprotein composition and metabolism.

  1989cited by this paper
• Plasma very low density lipoproteins contain a single molecule of apolipoprotein B.

  1988cited by this paper
• Hepatic acyl-CoA:cholesterol acyltransferase. Development of a standard assay and determination in patients with cholesterol gallstones.

  1986cited by this paper
• Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism.

  1985cited by this paper
• Cholestyramine-induced changes in low density lipoprotein composition and metabolism. I. Studies in the guinea pig.

  1985cited by this paper
• Receptor-mediated endocytosis of low-density lipoprotein in cultured cells.

  1983cited by this paper
• Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B.

  1983cited by this paper
• Properties and interpretation of the Woolf and Scatchard plots in analysing data from steroid receptor assays.

  1983cited by this paper
• Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

  1982cited by this paper
• Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man.

  1979influential reference
• A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

  1978influential reference
• Separation of plasma lipoproteins by density-gradient ultracentrifugation.

  1975influential reference
• Enzymatic determination of total serum cholesterol.

  1974cited by this paper
• Thin-layer chromatographic assay for HMG-CoA reductase and mevalonic acid.

  1969cited by this paper
• The use of a non‐ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions

  1967cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper

• Synergistic Effectiveness of Crude Extract Leaves of Moringa Oleifera Lam and Atorvastatin-Treated Rabbits

  2025cites this paper
• Anti-Dyslipidemic Potential of Sulfated Glycosaminoglycan from Rock Oyster Saccostrea cucullata: An in vivo study.

  2025cites this paper
• Toxic Effects of Acute and Chronic Atorvastatin Exposure on Antioxidant Systems, Autophagy Processes, Energy Metabolism and Life History in Daphnia magna.

  2024cites this paper
• High-fat diet induced alterations in plasma membrane cholesterol content impairs insulin receptor binding and signalling in mouse liver but is ameliorated by atorvastatin.

  2022cites this paper
• Nutriphenomics in Rodent Models

  2019cites this paper
• The Prevalence of Dysphonia and Dysphagia Symptoms in Patients on Statin Therapy.

  2019cites this paper
• Statins in critical care: to give or not to give?

  2017cites this paper
• Investigating DHCR24 as a protector against cellular stress : more than just a cholesterol-synthesising enzyme

  2017cites this paper
• Effects of Statins on Cardiovascular Outcomes in Patients With Chronic Kidney Disease

  2017cites this paper
• A novel therapeutic effect of statins on nephrogenic diabetes insipidus

  2015cites this paper
• THE HEPATOPROTECTIVE EFFECT OF HIBISCUS ROSA SINENSIS FLOWER EXTRACT ON DIET - INDUCED HYPERCHOLESTEROLEMIA IN MALE ALBINO WISTAR RATS

  2014cites this paper
• Development and validation of a RP-HPLC method for assay of Atorvastatin and its application in dissolution studies on thermosensitive hydrogel-based nanocrystals

  2014cites this paper
• Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence

  2014cites this paper
• High-dose supplementation with natural α-tocopherol does neither alter the pharmacodynamics of atorvastatin nor its phase I metabolism in guinea pigs.

  2013cites this paper
• Comparative Study of Ezetimibe and Atorvastatin Alone and in Combination on Lipid Profile in Rats

  2013cites this paper
• High fat diets and pathology in the guinea pig. Atherosclerosis or liver damage?

  2013cites this paper
• Hypocholesterolemic Effect of Dietary Apple Polyphenol Is Associated with Alterations in Hepatic Gene Expression Related to Cholesterol Metabolism in Rats

  2013cites this paper
• “SUB-ACUTE ORAL TOXICITY STUDY OF ATORVASTATIN ALONE AND IN COMBINATION WITH VERAPAMIL FOLLOWING REPEATED ADMINISTRATION IN HYPERLIPIDEMIC RATS”

  2012cites this paper
• TRP Channels in Drug Discovery

  2012cites this paper
• Atorvastatin

  2012cites this paper
• Using Diet to Induce Metabolic Disease in Rodents

  2012cites this paper
• Influence of atorvastatin on fractional and subfractional composition of serum lipoproteins and MMP activity in mice with Triton WR 1339‐induced lipaemia

  2011cites this paper
• Archive of SID Pharmacological management of metabolic syndrome and its lipid complications

  2010cites this paper
• Process of care for carotid endarterectomy: perioperative medical management.

  2010cites this paper
• Pharmacological management of metabolic syndrome and its lipid complications

  2010cites this paper
• Models to study atherosclerosis: a mechanistic insight.

  2009cites this paper
• (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential.

  2008cites this paper
• Effect of onion and beet on plasma and liver lipids, platelet aggregation, and erythrocyte Na efflux in simvastatin treated hypercholesterolmic rats

  2008cites this paper
• Atorvastatin and cardiovascular risk in the elderly – patient considerations

  2008cites this paper
• Experimental hyperlipidaemia does not prevent preconditioning and it reduces ischemia-induced apoptosis.

  2008cites this paper
• Replacing dietary carbohydrate with protein and fat decreases the concentrations of small LDL and the inflammatory response induced by atherogenic diets in the guinea pig.

  2008cites this paper
• Carbohydrate restriction alters hepatic cholesterol metabolism in guinea pigs fed a hypercholesterolemic diet.

  2007cites this paper
• Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties

  2007cites this paper
• The Role of Statin Drugs in the Management of the Peripheral Vascular Patient

  2006cites this paper
• Guinea pigs: A suitable animal model to study lipoprotein metabolism, atherosclerosis and inflammation

  2006influential citation
• Cerivastatin and hypercholesterolemia reduce apoptosis of cardiomyocytes in guinea pig papillary muscle subjected to hypoxia/reoxygenation.

  2006cites this paper
• Guinea pigs as models to study the hypocholesterolemic effects of drugs.

  2006cites this paper
• Role of Thyroid Disease in the Development of Statin-Induced Myopathy

  2006cites this paper
• JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs

  2005cites this paper
• High intake of cholesterol results in less atherogenic low-density lipoprotein particles in men and women independent of response classification.

  2004cites this paper
• Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs.

  2003cites this paper
• Pharmaceutical initiatives to combat atherosclerosis--what to do with the good, the bad, and the ugly lipoproteins.

  2002cites this paper
• Experimental model of escape phenomenon in hamsters and the effectiveness of YM‐53601 in the model

  2002cites this paper
• 1-[4-[4[(4R,5R)-3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]butyl]-4-aza-1-azoniabicyclo[2.2.2]octane Methanesulfonate (SC-435), an Ileal Apical Sodium-Codependent Bile Acid Transporter Inhibitor Alters Hepatic Cholesterol Metabolism and Lowers

  2002influential citation
• Gender and hormonal status affect the regulation of hepatic cholesterol 7alpha-hydroxylase activity and mRNA abundance by dietary soluble fiber in the guinea pig.

  2002cites this paper
• octane Methanesulfonate ( SC-435 ) , an Ileal Apical Sodium-Codependent Bile Acid Transporter Inhibitor Alters Hepatic Cholesterol Metabolism and Lowers Plasma Low-Density Lipoprotein-Cholesterol Concentrations in Guinea Pigs

  2002influential citation
• Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes.

  2002cites this paper
• Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells.

  2001cites this paper
• Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells.

  2001cites this paper
• Soluble fiber and soybean protein reduce atherosclerotic lesions in guinea pigs. Sex and hormonal status determine lesion extension

  2001influential citation
• Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.

  2001cites this paper
• Guinea pigs as models for cholesterol and lipoprotein metabolism.

  2001influential citation
• Cholesterol-lowering Effect of NK-104, a 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitor, in Guinea Pig Model of Hyperlipidemia

  2001cites this paper
• The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy.

  2000cites this paper
• Atorvastatin and the plasma activities of lipoprotein lipase, hepatic lipase and lecithin:cholesterol acyltransferase in patients with mixed hyperlipidemia

  2000cites this paper
• The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy

  2000cites this paper
• Gender and hormonal status affect the hypolipidemic mechanisms of dietary soluble fiber in guinea pigs.

  2000cites this paper
• Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes.

  2000cites this paper
• Governance of the concentration of plasma LDL: a reevaluation of the LDL receptor paradigm.

  2000cites this paper
• Oxysterols: modulators of cholesterol metabolism and other processes.

  2000cites this paper
• [The hyperlipidemias. Role of various statins].

  1999cites this paper
• Different effect of simvastatin and atorvastatin on key enzymes involved in VLDL synthesis and catabolism in high fat/cholesterol fed rabbits

  1999cites this paper
• Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin.

  1999cites this paper
• The Magnitude of Decrease in Hepatic Very Low Density Lipoprotein Apolipoprotein B Secretion Is Determined by the Extent of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition in Miniature Pigs1.

  1999cites this paper
• Manipulation of cholesterol and cholesteryl ester synthesis has multiple effects on the metabolism of apolipoprotein B and the secretion of very-low-density lipoprotein by primary hepatocyte cultures.

  1999cites this paper
• Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs.

  1999cites this paper
• Effects of Statins in Thrombosis and Aortic Lesion Development in a Dyslipemic Rabbit Model

  1999cites this paper
• Select 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors vary in their ability to reduce egg yolk cholesterol levels in laying hens through alteration of hepatic cholesterol biosynthesis and plasma VLDL composition.

  1999cites this paper
• Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.

  1999cites this paper
• Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig

  1999cites this paper
• The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.

  1999influential citation
• Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin.

  1998cites this paper
• The Sterol-Specific Regulation of ACAT-1 and SREBPs in Mammalian Cells and in Liver

  1998cites this paper
• Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity.

  1998influential citation
• Defects of lipoprotein metabolism in familial combined hyperlipidaemia.

  1998cites this paper
• Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.

  1998cites this paper
• Atorvastatin in the Treatment of Primary Hypercholesterolemia and Mixed Dyslipidemias

  1998cites this paper
• Lime-treated corn husks lower plasma LDL cholesterol in guinea pigs by altering hepatic cholesterol metabolism

  1997cites this paper
• Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.

  1997cites this paper
• 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion.

  1997cites this paper